Company intelligence / Profile preview

DNTOX GmbH

Düsseldorf, Nordrhein-Westfalen, Germanydntox.de ↗

Ownership: Private
Development stage: Commercial

Overview

DNTOX provides animal-free, AI-powered in vitro testing services for assessing the developmental and adult neurotoxic potential of chemicals. Their platform uses advanced human cell models to deliver high-content data for chemical safety evaluation. The company is not developing therapeutics but offers a commercial service platform that has received industry recognition and seed funding.

Therapeutic areas: Neurology
Modalities: In vitro human cell models (human neural progenitor cells, hNPCs; human induced pluripotent stem cells, hiPSCs)2D and 3D cell culture systems
Industry: Drug Discovery Services

Beyond the preview

Go deeper on DNTOX GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNTOX GmbH.

Explore the full profile